In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)

Preferentially Expressed Antigen in Melanoma (PRAME) is a cancer/testis antigen that is overexpressed in a broad range of malignancies, while absent in most healthy human tissues, making it an attractive diagnostic cancer biomarker and therapeutic target. Although commonly viewed as an intracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Pankov, Dmitry, Sjöström, Ludvig, Kalidindi, Teja, Lee, Sang-Gyu, Sjöström, Kjell, Gardner, Rui, McDevitt, Michael R., O’Reilly, Richard, Thorek, Daniel L.J., Larson, Steven M., Veach, Darren, Ulmert, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630382/
https://www.ncbi.nlm.nih.gov/pubmed/29029482
http://dx.doi.org/10.18632/oncotarget.19579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630382/
https://www.ncbi.nlm.nih.gov/pubmed/29029482
http://dx.doi.org/10.18632/oncotarget.19579

Ejemplares similares